首页> 外文期刊>The journal of asthma >Comparison of methacholine and adenosine inhalation challenge in patients with suspected asthma.
【24h】

Comparison of methacholine and adenosine inhalation challenge in patients with suspected asthma.

机译:疑似哮喘患者甲乙酰胆碱和腺苷吸入挑战的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Bronchial hyperresponsiveness is usually measured by bronchial challenge with direct (e.g. methacholine) and indirect (e.g. adenosine) agonists. A prospective, randomized, crossover, single-blind study was performed to compare both methods in the first diagnosis of asthma. PATIENTS AND METHODS: Fifty-seven patients, in which asthma was suspected, were selected (21 male, 36 female). Fifty-four underwent both challenges following the five-breath dosimeter protocol. PC20 was calculated according to ATS guidelines. Data of symptoms developed during the challenge, PC20 methacholine and adenosine, and FEV1 improvement after bronchodilator therapy were recorded. RESULTS: Symptoms at consultation were consistent with asthma in 68.4% patients, asthma and rhinitis in 29.8% and exercise-induced asthma in 1.8%. Atopy was reported in 93%; 49.1% had family history of atopy and 26.3% of asthma. The most frequent symptoms developed during the challenge were cough (40.4% with adenosine and 20.4% with methacholine) and wheezing (26.3% and 7.4% respectively), statistically significant differences. Bronchial challenge with MCh resulted positive in 44.4% of the patients and positive with AMP in 50%. Every patient with negative result to adenosine, was also negative to methacholine. In 94.4% subjects the result of both challenges was concordant (kappa index = 0.889). PC20 in both challenges showed poor linear correlation (Pearson r = 0.43, p < 0.05). Positivity of both challenges was only associated with having a positive skin prick test to danders (p = 0.001). Percentage of improvement after bronchodilator was 34.9% (SD12.2%) with adenosine challenge and 33.9% (SD17.9%) with methacholine (differences non statistically significant). CONCLUSIONS: Concordance in the result of both techniques is very high. Cough and wheezing are more frequent with adenosine, though not severe. PC20 with both techniques shows poor linear correlation.
机译:目的:支气管高反应性通常通过使用直接(例如,乙酰甲胆碱)和间接(例如,腺苷)激动剂的支气管激发来测量。进行了一项前瞻性,随机,交叉,单盲研究,以比较两种方法在首次诊断哮喘中的作用。患者与方法:选择了57例怀疑患有哮喘的患者(男性21例,女性36例)。在五口气剂量计协议之后,有五十四项经历了两个挑战。 PC20是根据ATS指南计算的。记录攻击过程中出现的症状,支气管扩张剂治疗后PC20乙酰甲胆碱和腺苷以及FEV1改善的症状。结果:会诊时症状与哮喘68.4%,哮喘和鼻炎29.8%,运动性哮喘1.8%一致。特应性报道为93%。 49.1%有特应性家族病史,26.3%有哮喘病史。攻击过程中最常见的症状是咳嗽(腺苷占40.4%,乙酰甲胆碱占20.4%)和喘息(分别为26.3%和7.4%),差异有统计学意义。 MCh的支气管激发导致44.4%的患者阳性,而AMP阳性的患者占50%。每位腺苷结果阴性的患者,对乙酰甲胆碱也阴性。在94.4%的受试者中,两次挑战的结果是一致的(kappa指数= 0.889)。在两个挑战中,PC20均显示出差的线性相关性(Pearson r = 0.43,p <0.05)。这两个挑战的积极性仅与皮屑皮毛试验阳性有关(p = 0.001)。支气管扩张剂用腺苷激发后改善的百分比为34.9%(SD12.2%),并用乙酰甲胆碱改善为33.9%(SD17.9%)(差异无统计学意义)。结论:两种技术的结果一致性很高。腺苷虽然不严重,但咳嗽和喘息更为频繁。两种技术的PC20都显示出较差的线性相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号